CONTAGIOUS COMMENTS Department of Epidemiology

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "CONTAGIOUS COMMENTS Department of Epidemiology"

Transcription

1 VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007 TCH annual antibiogram again shows an increase in resistant organisms that are not easily detected by standard testing methodologies. This requires clinical laboratories to develop new testing methods and staff expertise to recognize them. Although we have added MRSA to our daily vocabulary, both gram negative and gram positive organisms have shown increasing rates of new mechanisms of resistance. MRSA continues to increase in both our emergency departments (including Network of Care, Urgent Care and the Child Health Clinic) and our inpatient population. Because of the implications of the spread of this resistant organism, TCH s Microbiology laboratory is validating a new PCR assay on our GeneXpert that will allow faster screening of high risk patients. This faster screening will allow isolation precautions to be shortened for MRSA negative patients. The D test has been used for several years to detect the erm gene that confers inducible clindamycin resistance to Staphylococcus aureus. The D test is performed prior to reporting clindamycin susceptibility for S. aureus. The erm gene is also found in Group A streptococcus and is automatically tested in our lab prior to reporting susceptibilities. In 2007, 22 Group A strep isolates were tested with none showing the inducible erm gene that would indicate clindamycin resistance. Our number of VRE (Vancomycin Resistant Enterococcus) isolates, although low, has increased from one in 2006 to five in VRE has been isolated from significant sources and we reported our first blood culture isolate this year. Gram negative bacteria also continue to mutate and acquire new resistance enzymes that are not easily detected by standard susceptibility testing. Perhaps the most challenging for the laboratory has been Extended-Spectrum Beta Lactamases (ESBLs). Typically, ESBLs are mutant, plasmid-mediated beta-lactamases derived from older broad spectrum beta-lactamases which have extended substrate profiles that permit hydrolysis of all cephalosporins, penicillins, and aztreonam. The production of AmpC beta-lactamases by gram negative bacteria further complicates susceptibility testing. AmpC beta lactamases differ from ESBLs in that they are cephalosporinases and confer resistance to beta lactamase inhibitors. AmpC is normally produced in low levels by many gram negative organisms and is not associated with resistance. When AmpC is produced at high levels there is resistance to all beta-lactams except carbapenems and 4 th generation cephalosporins (e.g. Cefipime). ESBL (Extended-Spectrum Beta Lactamase) isolates this year have showed a significant increase from 3 to 13. The majority of these isolates were from urine specimens, but one isolate was from a blood culture. In Table 1, Enterobacter cloacae urine isolates showed a marked decrease in susceptibility and differed from the non-urine isolates. This phenomenon of decreased susceptibility of this organism in non-icu units has been reported at other institutions and is making an impact on patient care. (see page 2 for Table 1.)

2 TABLE 1. Antimicrobial Susceptibilities at The Children s Hospital 2007 Gram Negative Organisms (% susceptible) NUMBER OF ISOLATES Ampicillin / Amoxicillin Cefazolin / cephalexin Cefuroxime Cefotaxime/ ceftriaxone Gentamicin Tobramycin Trimethoprim / sulfa Ciprofloxaci 1 Haemophilus species E. coli (urine) E. coli (non-urine) Enterobacter cloacae (urine) (21) R R Enterobacter cloacae (non-urine) 45 R R Klebsiella pneumoniae 69 R Klebsiella oxytoca (28) R Proteus mirabilis (24) Salmonella species (20) Serratia marcescens (20) R R Shigella species (6) Testing by Microscan panels (except Haemophilus by E-test) 1 Ciprofloxacin is FDA approved for children greater than 1 year of age for complicated UTIs. 13 Isolates identified as ESBL.- includes one stool surveillance culture R = Resistant (Intrinsic) ( ) Small number of isolates MRSA Rates for TCH Patients 60% 50% Rate 40% 30% 20% MRSA Rate ED Rate Non-ED Rate 10% 0% Year VOLUME XXIII NUMBER 1 July/August 2008 Page 2

3 TCH s microbiology laboratory will be validating new susceptibility testing panels that will detect ESBLs in CLSI recommended organisms including: E. coli, Klebsiella species, and Proteus mirabilis. Having the confirmatory assay within the panel will shorten the turnaround time to a final report by a day and will also allow us to screen for ESBLs in Enterobacter cloacae. The bugs continue to put up a good fight as the antibiotic arsenal is decreasing. What can you do? 1. Obtain good specimens to send to the microbiology lab for culture. This translates to fluid samples where a gram stain may be done and avoiding the use of swabs for culture. 2. Check microbiology culture results and susceptibility patterns so that you can make sure you are treating with an appropriate antibiotic. 3. Use a narrow spectrum antibiotic when possible to decrease antibiotic pressure and development of resistance. 4. Prevent infection by practicing tried and true good infection control practices: protect yourself and your patient by adhering to isolation precautions and by all means wash your hands. VOLUME XXIII NUMBER 1 July/August 2008 Page 3

4 Additional graphs from: ANTIBIOTIC SUSCEPTIBILITY OF BACTERIA & YEAST Elaine Dowell, SM (ASCP) Technical Supervisor of Microbiology Marti Roe, SM (ASCP) Technical Consultant for Microbiology James K. Todd, MD Clinical Director of Microbiology Ann-Christine Nyquist, MD, MSPH January 1, 2007 December 31, 2007 TABLE 2. Antimicrobial Susceptibilities at The Children s Hospital 2007 Non-Enterobacteriaceae (% susceptible) NUMBER OF ISOLATES Ticarcillin/clav Timentin Piperacillin Ceftazidime Aztreonam Imipenem / Cilastatin Ciprofloxacin 3 Gentamicin Tobramycin Meropenem Piperacillin / Taz Minocycline Trimeth / Sulfa *Acinetobacter species 1 (22) Pseudomonas aeruginosa Non CF CF-mucoid CF-nonmucoid *A. xylosoxidans 1 (29) Stenotrophomonas maltophilia Cystic fibrosis isolates by E-test. May include >1 isolate/patient. Testing by Microscan Ciprofloxacin is FDA approved for children greater than 1 year of age for complicated UTIs. * 2006 and 2007 data combined ( ) Small number of isolates TABLE 3. Antimicrobial Susceptibilities at The Children s Hospital 2007 Staphylococcus (% susceptible) NUMBER OF ISOLATES TESTED Penicillin Oxa-/ Naf-/ Dicloxacillin Cefazolin Cephalexin Trimethoprim / Sulfa Erythromycin Clindamycin Vancomycin Staph aureus Staph aureus (MSSA) Staph aureus (MRSA) Staph epidermidis Testing by Microscan panels Confirmation of MRSA by PBP2 testing and Chromagar VOLUME XXIII NUMBER 1 July/August 2008 Page 4

5 TABLE 4. Antimicrobial Susceptibilities at The Children s Hospital 2007 Streptococcus (% susceptible) Penicillin Cefotaxime NUMBER OF ISOLATES S < 0.06 I = R > 2 S < 0.5 I = 1 R > 2 Erythromycin Clindamycin Trimethoprim/ Sulfa Cefotaxime Ampicillin/ Amoxicillin Vancomycin S. pneumoniae 1 Invasive S. pneumoniae 1 Localized (resp.) (22) Viridans Strep 1 Invasive Strep. anginosus 1 Group Invasive Enterococcus 2 faecalis Enterococcus 2 faecium 1 Testing by E-test. 2 Testing by Microscan panel (21) * Gentamicin Synergy Screen E. faecalis = 76% Susceptible Gentamicin Synergy Screen E. faecium = 91% Susceptible * 5 VRE patients * data combined Table 5. Antimicrobial Susceptibilities at The Children s Hospital 2007 Candida albicans (# of isolates susceptible) Streptococcus (% susceptible) Fluconazole NUMBER OF ISOLATES S < 8 I = R > 64 Candida albicans (21) 21 Testing by UTHSC (at San Antonio) combined VOLUME XXIII NUMBER 1 July/August 2008 Page 5

6 CONTAGIOUS COMMENTS Department of Epidemiology EDITOR: Kelly DeStefano, Staff Assistant III The Children s Hospital, Dept. of Epidemiology, B-276 th E. 16 Avenue, Aurora, CO Phone: ; FAX: **We Recycle!** The Department of Epidemiology at The Children s Hospital We are modifying our distribution process for Bug Watch and Contagious Comments. Below are the methods of distribution that we will be using. Please provide us with your preferred method of distribution. Name: (please provide your address): Fax (please provide us with your fax number and who the fax should be directed to): ( ) Both of these publications are always posted on The Children s Hospital website at: Please return your preference to: Carolyn Brock, The Children s Hospital, Epidemiology Box B276, E. 16 th Avenue, Aurora, CO or address: Thank you for your interest in our publication.

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),

More information

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data Trevor Van Schooneveld MD, Scott Bergman, PharmD, BCPS, Paul Fey, PhD, Mark Rupp, MD The Clinical Microbiology laboratory

More information

HUSRES Annual Report 2007 Martti Vaara.

HUSRES Annual Report 2007 Martti Vaara. HUSRES Annual Report 2007 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2007 report is the HUSLAB/Whonet database 2007, which contains susceptibility data on about 182.000 bacteria

More information

Antimicrobial Susceptibility Summary 2012

Antimicrobial Susceptibility Summary 2012 Antimicrobial Susceptibility Summary 2012 Clinical Microbiology Department of Pathology & Laboratory Medicine 46 53 Antimicrobial Susceptibility Summary Clinical Microbiology Department of Pathology and

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Antimicrobial Susceptibility Summary 2011

Antimicrobial Susceptibility Summary 2011 Antimicrobial Susceptibility Summary 2011 Clinical Microbiology Department of Pathology & Laboratory Medicine 45 Antimicrobial Susceptibility Summary Clinical Microbiology Department of Pathology and Laboratory

More information

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Taiwan Surveillance of Antimicrobial Resistance (TSAR) Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011 Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond

More information

Antimicrobial Resistance Trends in the Province of British Columbia

Antimicrobial Resistance Trends in the Province of British Columbia 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2443 Fax 604.707.2441 www.bccdc.ca Antimicrobial Resistance Trends in the Province of British Columbia 2013 Prepared by the Do Bugs Need Drugs? Program

More information

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM April Abbott, PhD, D(ABMM) Deaconess Health System Evansville, IN April.Abbott@Deaconess.com Special thanks to Dr. Shelley Miller for UCLA data WHAT WE WILL COVER

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level janet hindler At the conclusion of this talk, you will be able to Describe CLSI M39-A3 recommendations

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification Cell Wall Weakeners Antimicrobials: Drugs that Weaken the Cell Wall Beta Lactams Penicillins Cephalosporins Carbapenems Aztreonam Vancomycin Teicoplanin Bacterial Cell Wall Bacterial cytoplasm is hypertonic

More information

The Cost of Antibiotic Resistance: What Every Healthcare Executive Should Know

The Cost of Antibiotic Resistance: What Every Healthcare Executive Should Know The Cost of Antibiotic Resistance: What Every Healthcare Executive Should Know JCR National Infection Prevention and Control Conference 2009 Mastering Powerful and Practical Infection Prevention Strategies

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

Management of Hospital-acquired Pneumonia

Management of Hospital-acquired Pneumonia Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

Fundamental Concepts in the Use of Antibiotics. Case. Case. TM is a 24 year old male admitted to ICU after TBI and leg fracture from MVA ICU day 3

Fundamental Concepts in the Use of Antibiotics. Case. Case. TM is a 24 year old male admitted to ICU after TBI and leg fracture from MVA ICU day 3 Fundamental Concepts in the Use of Antibiotics Todd Miano, PharmD, MSCE Critical Care Pharmacist Pharmacoepidemiology Fellow Perelman School of Medicine at the University of Pennsylvania Case TM is a 24

More information

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory

More information

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and Health-Care Associated Infections Overall Goals & Objectives:

More information

Beta-lactam antibiotics - Cephalosporins

Beta-lactam antibiotics - Cephalosporins Beta-lactam antibiotics - Cephalosporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability ypropertiesp Stability to bacterial

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Antimicrobial Resistance Strains

Antimicrobial Resistance Strains Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant

More information

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis

More information

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient 1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime

More information

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

Management of Antibiotic Resistant Pathogens

Management of Antibiotic Resistant Pathogens Management of Antibiotic Resistant Pathogens Jonathan J. Juliano, MD, MSPH Assistant Professor UNC School of Medicine Director of Antibiotic Stewardship UNC Hospitals, Chapel Hill SPICE Conference Friday

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

Resistant Infections: Superbugs and No Superdrugs

Resistant Infections: Superbugs and No Superdrugs Resistant Infections: To the SNF and Back Elizabeth Hudson, DO, MPH Department of Infectious Diseases Panorama City 9/15/12 Superbugs and No Superdrugs Antibiotics are often taken for granted Changes over

More information

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

Summary of the latest data on antibiotic resistance in the European Union

Summary of the latest data on antibiotic resistance in the European Union Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network

More information

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

TITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline

TITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline Site: Saint Joseph Hospital - NICU Original Effective Date: 6/1/2016 Next Review Date: 6/1/2019 TITLE: Practice Guideline Purpose: Timely and appropriate treatment of late-onset sepsis with antibiotic

More information

Management of Antibiotic Resistant Pathogens. Zach Willis, MD, MPH Department of Pediatrics, UNC 11/8/2017

Management of Antibiotic Resistant Pathogens. Zach Willis, MD, MPH Department of Pediatrics, UNC 11/8/2017 Management of Antibiotic Resistant Pathogens Zach Willis, MD, MPH Department of Pediatrics, UNC 11/8/2017 I have no disclosures Overview Introduction Burden of antibiotic resistance (AR) focus on inpatient

More information

BACTERIOLOGICAL PROFILE OF OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL AT VISAKHAPATNAM, ANDHRA PRADESH

BACTERIOLOGICAL PROFILE OF OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL AT VISAKHAPATNAM, ANDHRA PRADESH IJCRR Vol 05 issue 20 Section: Healthcare Category: Research Received on: 07/09/13 Revised on: 02/10/13 Accepted on: 24/10/13 BACTERIOLOGICAL PROFILE OF OSTEOMYELITIS IN A TERTIARY CARE HOSPITAL AT VISAKHAPATNAM,

More information

Helen Heffernan. Rosemary Woodhouse

Helen Heffernan. Rosemary Woodhouse ANTIMICROBIAL RESISTANCE AMONG GRAM-NEGATIVE BACILLI FROM BACTERAEMIA, 2007 Helen Heffernan Rosemary Woodhouse Antibiotic Reference Laboratory Communicable Disease Group Institute of Environmental Science

More information

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?

More information

Antimicrobial susceptibility of clinical isolates from earthquake victims in Wenchuan

Antimicrobial susceptibility of clinical isolates from earthquake victims in Wenchuan ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02129.x Antimicrobial susceptibility of clinical isolates from earthquake victims in Wenchuan M. Kang 1,2, Y. Xie 1, C. Mintao 1, Z. Chen 1, H. Chen 1, H. Fan

More information

Nosocomial Infections: What Are the Unmet Needs

Nosocomial Infections: What Are the Unmet Needs Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,

More information

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Service Delivery and Safety Department World Health Organization, Headquarters

Service Delivery and Safety Department World Health Organization, Headquarters Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

Updates on the Management of Hospital Acquired Infections and Resistant Organisms

Updates on the Management of Hospital Acquired Infections and Resistant Organisms Updates on the Management of Hospital Acquired Infections and Resistant Organisms Kaitlin McGinn, PharmD Assistant Clinical Professor, Critical Care Auburn University, Harrison School of Pharmacy November

More information

Antimicrobial Resistance

Antimicrobial Resistance Antimicrobial Resistance Anna-Kathryn Burch, M.D. February 17, 2016 Disclosures I have nothing to disclose. Objectives Discuss antimicrobial resistance Discuss Antimicrobial Stewardship Programs (ASP)

More information

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;

More information

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control

More information

Liofilchem. ID-AST systems

Liofilchem. ID-AST systems Liofilchem ID-AST systems Systems for ID and AST directly from clinical specimens page 1 Integral Systems for ID and AST from isolated colonies page 4 Systems for ID from isolated colonies page 6 Systems

More information

Community Acquired MRSA Infections

Community Acquired MRSA Infections Community Acquired MRSA Infections (Guess What, its NOT a Spider Bite!) Sarmistha B. Hauger M.D. Pediatric Infectious Diseases Specially For Children Dell Children s Medical Center DCMC CME Conference

More information

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated

More information

2/22/11. Antibiotics for the Hospitalized Patient

2/22/11. Antibiotics for the Hospitalized Patient Antibiotics for the Hospitalized Patient B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco A 67 year old man with

More information

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation

More information

CAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods

CAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods CAP Laboratory Improvement Programs Performance Accuracy of Antibacterial and Antifungal usceptibility Test Methods Report From the College of American Pathologists Microbiology urveys Program (001 003)

More information

ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF ENTEROBACTERIACEAE ISOLATED FROM URINE SAMPLES AT THE KENYATTA NATIONAL HOSPITAL MICROBIOLOGY LABORATORY

ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF ENTEROBACTERIACEAE ISOLATED FROM URINE SAMPLES AT THE KENYATTA NATIONAL HOSPITAL MICROBIOLOGY LABORATORY ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF ENTEROBACTERIACEAE ISOLATED FROM URINE SAMPLES AT THE KENYATTA NATIONAL HOSPITAL MICROBIOLOGY LABORATORY DR. SIMON K. NJIRU (M.B.Ch.B U.o.N) A DISSERTATION SUBMITTED

More information

Antibiotics 1. Lecture 8

Antibiotics 1. Lecture 8 Antibiotics 1 Lecture 8 Overview of antibiotics What am I treating? Viral, bacterial, fungal, mycobacterial, etc. Who am I treating? Host factors: age, genetic factors, co-morbidities (renal and liver

More information

Monitoring of AMR in Russia

Monitoring of AMR in Russia Monitoring of AMR in Russia Surveillance studies conducted by Institute of Antimicrobial Chemotherapy (IAC) Centre for Monitoring of Antimicrobial Resistance (CMAR) Prospective surveillance studies on

More information

Antibiotic stewardship in long term care

Antibiotic stewardship in long term care Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical

More information

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 37/ May 07, 2015 Page 6443

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 37/ May 07, 2015 Page 6443 A RETROSPECTIVE ANALYSIS ON ANTIMICROBIAL SENSITIVITY PATTERN IN A MEDICAL COLLEGE HOSPITAL IN KANNUR DISTRICT R. Ratheesh 1, Bindu Mohandas 2, Sahadevan 3, P. P. Venugopalan 4 HOW TO CITE THIS ARTICLE:

More information

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS LABORATORIES ON THE FRONT LINE From the National Action Plan for Combating Antibiotic Resistant

More information

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...

More information

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria

Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria Cleaning and Disinfection Protocol for Gram-Negative and Gram-Positive Bacteria, including Antibiotic Resistant Bacteria This document has been developed in accordance with current applicable infection

More information

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone

More information

Study of Bacterial Infections Among Patients Receiving Kidney Transplant in Mashhad, Iran

Study of Bacterial Infections Among Patients Receiving Kidney Transplant in Mashhad, Iran ArtIcle Study of Bacterial Infections Among Patients Receiving Kidney Transplant in Mashhad, Iran Davood Mansury, 1,5 Azad Khaledi, 2 Kiarash Ghazvini, 1 Mahin Ghorban Sabbagh, 3 Hosna Zare, 1 Mohammad

More information

Principles in antimicrobial therapy: The ABCs

Principles in antimicrobial therapy: The ABCs Principles in antimicrobial therapy: The ABCs Benjamin G. Co, MD, FPPS, FPSECP Professorial lecturer in Antimicrobial Therapy, Graduate School University of Santo Tomas Executive Director, Center for Drug

More information

Occurrence of Beta- Lactamase Resistance among Isolates from Cancer Patients in Lagos, Nigeria

Occurrence of Beta- Lactamase Resistance among Isolates from Cancer Patients in Lagos, Nigeria Researcher, 2009; 1(6) Occurrence of Beta- Lactamase Resistance among Isolates from Cancer Patients in Lagos, Nigeria Eyitayo.O.Adenipekun, Ibukun.E.Aibinu, Oluwole.A.Daini, Afolabi.Ogunledun, A, Aderemi.T.

More information

Antibiotics 201: Gramnegatives

Antibiotics 201: Gramnegatives Antibiotics 201: Gramnegatives B. Joseph Guglielmo, Pharm.D. Professor and Dean School of Pharmacy University of California San Francisco Disclosures No potential conflicts of interest. 1 A 77 year old

More information

Detection of Methicillin Resistant, ESBL and Amp C Producing Uropathogens from a Tertiary Care Hospital in North India

Detection of Methicillin Resistant, ESBL and Amp C Producing Uropathogens from a Tertiary Care Hospital in North India International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 770-778 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.096

More information

Infection Prevention & Control: PPE and Beyond. Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control

Infection Prevention & Control: PPE and Beyond. Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control Infection Prevention & Control: PPE and Beyond Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control Objectives Describe the chain of infection Explain the role of personal protective equipment

More information

Disclosures. Respiratory Infection and Antibiotics. What is the treatment of choice for ABRS? Acute Bacterial Rhinosinusitis

Disclosures. Respiratory Infection and Antibiotics. What is the treatment of choice for ABRS? Acute Bacterial Rhinosinusitis Respiratory Infection and Antibiotics B. Joseph Guglielmo, Pharm.D. Professor and Dean School of Pharmacy University of California San Francisco Disclosures No disclosures regarding conflict of interest

More information

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,

More information

Antibiotic Combinations: Should They Be Tested?

Antibiotic Combinations: Should They Be Tested? CLINICAL MICROBIOLOGY REVIEWS, Apr. 1988, p. 139-156 Vol. 1, No. 2 0893-8512/88/020139-18$02.00/0 Copyright 1988, American Society for Microbiology Antibiotic Combinations: Should They Be Tested? G. M.

More information

Carbapenemase-Producing Enterobacteriaceae (CPE)

Carbapenemase-Producing Enterobacteriaceae (CPE) Carbapenemase-Producing Enterobacteriaceae (CPE) September 21, 2017 Maryam Khan Peel Public Health Madeleine Ashcroft Public Health Ontario Objectives Differentiate the acronyms related to CPE (CPE,CPO,CRE,CRO)

More information

POLQM Quality Conference October 2 nd, 2017

POLQM Quality Conference October 2 nd, 2017 POLQM Quality Conference john.galbraith@viha.ca October 2 nd, 2017 Discuss the accuracy of results in microbiology, especially in susceptibility testing Review how well microbiology results are interpreted

More information

Critical impact of antimicrobial resistance

Critical impact of antimicrobial resistance New Antibiotics Kurt B. Stevenson, MD, MPH Professor of Medicine and Epidemiology Division of Infectious Diseases Department of Internal Medicine The Ohio State University College of Medicine Critical

More information

ANTIBIOTIC TREATMENT AND RESISTANCE IN CHRONIC WOUNDS OF VASCULAR ORIGIN

ANTIBIOTIC TREATMENT AND RESISTANCE IN CHRONIC WOUNDS OF VASCULAR ORIGIN DOI: 0.5386/cjmed-647 Original Research ANTIBIOTIC TREATMENT AND RESISTANCE IN CHRONIC WOUNDS OF VASCULAR ORIGIN VALENTINA TZANEVA, IRENA MLADENOVA, GALINA TODOROVA, DIMITAR PETKOV MHAT Trakia, Stara Zagora,

More information

Irrational use of antimicrobial agents often

Irrational use of antimicrobial agents often Antibiotic Resistance of Isolated Bacteria in 1 and Abdo-Rabbo A. 2 Irrational use of antimicrobial agents often leads to the multi-drug resistance microorganisms. This study is aimed at investigating

More information

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics: Hospital-acquired Infections Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

Research Article Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection

Research Article Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection Microbiology, Article ID 682304, 6 pages http://dx.doi.org/10.1155/2014/682304 Research Article Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory

More information

Nosocomial Antibiotic Resistant Organisms

Nosocomial Antibiotic Resistant Organisms Nosocomial Antibiotic Resistant Organisms Course Medical Microbiology Unit II Laboratory Safety and Infection Control Essential Question Does improved hand hygiene really reduce the spread of bacteria

More information

Reassessment of the "Class" Concept of Disk Susceptibility Testing

Reassessment of the Class Concept of Disk Susceptibility Testing Reassessment of the "Class" Concept of Disk Susceptibility Testing Disks versus Minimal Inhibitory Concentrations with Eleven Cephalosporins ARTHUR L. BARRY, PH.D., CLYDE THORNSBERRY, PH.D., RONALD N.

More information

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital, Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at

More information